TRIMBLE INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TRIMBLE INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 29, 2023 | $3.80B | Jan 16, 2025 |
| FY2023 | Dec 30, 2022 | $3.68B | Jan 16, 2025 |
| FY2023 | Dec 31, 2021 | $3.66B | Jan 16, 2025 |
| FY2022 | Jan 1, 2021 | $3.15B | Feb 17, 2023 |
| FY2021 | Jan 3, 2020 | $3.27B | Feb 23, 2022 |
| FY2020 | Dec 28, 2018 | $3.13B | Feb 26, 2021 |
| FY2017 | Dec 29, 2017 | $708.40M | Feb 27, 2018 |
| FY2017 | Sep 29, 2017 | $670.00M | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | $661.90M | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | $613.90M | Feb 27, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $3.59B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $3.68B | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $3.80B | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $3.68B | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $3.66B | Jan 16, 2025 |
| FY2022 | Jan 1, 2021 | $3.15B | Feb 17, 2023 |
| FY2019 | Jan 3, 2020 | $824.00M | Feb 28, 2020 |
| FY2019 | Sep 27, 2019 | $783.90M | Feb 28, 2020 |
| FY2019 | Jun 28, 2019 | $854.80M | Feb 28, 2020 |
| FY2019 | Mar 29, 2019 | $801.60M | Feb 28, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $2.48B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $2.40B | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $2.33B | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $2.11B | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.03B | Jan 16, 2025 |
| FY2022 | Jan 1, 2021 | $1.75B | Feb 17, 2023 |
| FY2019 | Jan 3, 2020 | $460.00M | Feb 28, 2020 |
| FY2019 | Sep 27, 2019 | $422.00M | Feb 28, 2020 |
| FY2019 | Jun 28, 2019 | $460.60M | Feb 28, 2020 |
| FY2019 | Mar 29, 2019 | $438.30M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $424.00M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $1.50B | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $311.30M | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $449.70M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $492.70M | Feb 26, 2024 |
| FY2022 | Jan 1, 2021 | $389.90M | Feb 17, 2023 |
| FY2019 | Jan 3, 2020 | $279.30M | Feb 28, 2020 |
| FY2019 | Sep 27, 2019 | $78.10M | Feb 28, 2020 |
| FY2019 | Jun 28, 2019 | $94.60M | Feb 28, 2020 |
| FY2019 | Mar 29, 2019 | $62.30M | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $592.00M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $460.70M | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $448.80M | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $510.90M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $561.00M | Feb 26, 2024 |
| FY2022 | Jan 1, 2021 | $419.80M | Feb 17, 2023 |
| FY2021 | Jan 3, 2020 | $375.90M | Feb 23, 2022 |
| FY2020 | Dec 28, 2018 | $320.70M | Feb 26, 2021 |
| FY2019 | Dec 29, 2017 | $235.70M | Feb 28, 2020 |
| FY2018 | Dec 30, 2016 | $180.40M | Feb 22, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $630.70M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $662.30M | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $664.30M | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $542.10M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $536.60M | Feb 26, 2024 |
| FY2022 | Jan 1, 2021 | $475.90M | Feb 17, 2023 |
| FY2021 | Jan 3, 2020 | $469.70M | Feb 23, 2022 |
| FY2020 | Dec 28, 2018 | $446.10M | Feb 26, 2021 |
| FY2019 | Dec 29, 2017 | $370.20M | Feb 28, 2020 |
| FY2018 | Dec 30, 2016 | $349.60M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $386.20M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $531.40M | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $597.10M | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $391.20M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $750.50M | Jan 16, 2025 |
| FY2022 | Jan 1, 2021 | $672.00M | Feb 17, 2023 |
| FY2021 | Jan 3, 2020 | $585.00M | Feb 23, 2022 |
| FY2020 | Dec 28, 2018 | $486.70M | Feb 26, 2021 |
| FY2019 | Dec 29, 2017 | $429.70M | Feb 28, 2020 |
| FY2014 | Jan 2, 2015 | $407.08M | Feb 25, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $25.30M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $33.60M | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | $42.00M | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | $43.20M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $46.10M | Jan 16, 2025 |
| FY2022 | Jan 1, 2021 | $56.80M | Feb 17, 2023 |
| FY2021 | Jan 3, 2020 | $69.00M | Feb 23, 2022 |
| FY2020 | Dec 28, 2018 | $67.60M | Feb 26, 2021 |
| FY2019 | Dec 29, 2017 | $43.70M | Feb 28, 2020 |
| FY2018 | Dec 30, 2016 | $26.00M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $9.31B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $9.49B | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | $9.54B | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | $7.27B | Jan 16, 2025 |
| FY2022 | Dec 31, 2021 | $7.10B | Feb 17, 2023 |
| FY2021 | Jan 1, 2021 | $6.88B | Feb 23, 2022 |
| FY2020 | Jan 3, 2020 | $6.64B | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | $5.78B | Feb 28, 2020 |
| FY2018 | Dec 29, 2017 | $4.32B | Feb 22, 2019 |
| FY2017 | Dec 30, 2016 | $3.67B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $3.48B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $3.74B | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | $5.04B | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | $3.22B | Jan 16, 2025 |
| FY2022 | Dec 31, 2021 | $3.15B | Feb 17, 2023 |
| FY2021 | Jan 1, 2021 | $3.28B | Feb 23, 2022 |
| FY2020 | Jan 3, 2020 | $3.52B | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | $3.10B | Feb 28, 2020 |
| FY2018 | Dec 29, 2017 | $1.90B | Feb 22, 2019 |
| FY2017 | Dec 30, 2016 | $1.37B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $5.84B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $5.75B | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | $4.50B | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | $4.05B | Jan 16, 2025 |
| FY2023 | Dec 31, 2021 | $3.94B | Feb 26, 2024 |
| FY2023 | Jan 1, 2021 | $3.60B | Feb 26, 2024 |
| FY2020 | Jan 3, 2020 | $3.12B | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | $2.67B | Feb 28, 2020 |
| FY2018 | Dec 29, 2017 | $2.41B | Feb 22, 2019 |
| FY2017 | Dec 30, 2016 | $2.31B | Feb 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $5.24B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $4.99B | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | $5.35B | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | $4.14B | Jan 16, 2025 |
| FY2023 | Dec 31, 2021 | $3.98B | Jan 16, 2025 |
| FY2022 | Jan 1, 2021 | $3.88B | Feb 17, 2023 |
| FY2021 | Jan 3, 2020 | $3.68B | Feb 23, 2022 |
| FY2020 | Dec 28, 2018 | $3.54B | Feb 26, 2021 |
| FY2019 | Dec 29, 2017 | $2.29B | Feb 28, 2020 |
| FY2018 | Dec 30, 2016 | $2.08B | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $3.39B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $3.76B | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | $2.44B | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | $2.23B | Jan 16, 2025 |
| FY2022 | Dec 31, 2021 | $2.17B | Feb 17, 2023 |
| FY2021 | Jan 1, 2021 | $1.89B | Feb 23, 2022 |
| FY2020 | Jan 3, 2020 | $1.60B | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | $1.27B | Feb 28, 2020 |
| FY2018 | Dec 29, 2017 | $1.08B | Feb 22, 2019 |
| FY2017 | Dec 30, 2016 | $1.18B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $253.40M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $738.80M | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | $229.80M | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | $271.00M | Jan 16, 2025 |
| FY2022 | Dec 31, 2021 | $325.70M | Feb 17, 2023 |
| FY2021 | Jan 1, 2021 | $237.70M | Feb 23, 2022 |
| FY2020 | Jan 3, 2020 | $189.20M | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | $172.50M | Feb 28, 2020 |
| FY2019 | Dec 29, 2017 | $358.50M | Feb 28, 2020 |
| FY2019 | Dec 30, 2016 | $216.10M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $1.39B | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | $1.39B | Feb 25, 2026 |
| FY2022 | Dec 30, 2022 | $1.22B | Feb 17, 2023 |
| FY2022 | Dec 31, 2021 | $1.29B | Feb 17, 2023 |
| FY2021 | Jan 1, 2021 | $1.29B | Feb 23, 2022 |
| FY2020 | Jan 3, 2020 | $1.62B | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | $1.97B | Feb 28, 2020 |
| FY2018 | Dec 29, 2017 | $913.90M | Feb 22, 2019 |
| FY2017 | Dec 30, 2016 | $619.90M | Feb 27, 2018 |
| FY2016 | Jan 1, 2016 | $729.70M | Feb 24, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | 1 | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | 6 | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | 1 | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 26, 2024 |
| FY2022 | Jan 1, 2021 | 1 | Feb 17, 2023 |
| FY2019 | Jan 3, 2020 | 1 | Feb 28, 2020 |
| FY2019 | Sep 27, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 28, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 29, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | 1 | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | 6 | Feb 25, 2026 |
| FY2025 | Dec 29, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 30, 2022 | 1 | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 26, 2024 |
| FY2022 | Jan 1, 2021 | 1 | Feb 17, 2023 |
| FY2019 | Jan 3, 2020 | 1 | Feb 28, 2020 |
| FY2019 | Sep 27, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 28, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 29, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | 236.00M | Feb 25, 2026 |
| FY2025 | Jan 3, 2025 | 245.80M | Feb 25, 2026 |
| FY2024 | Dec 29, 2023 | 246.50M | Apr 25, 2025 |
| FY2023 | Dec 30, 2022 | 246.90M | Jan 16, 2025 |
| FY2022 | Dec 31, 2021 | 250.90M | Feb 17, 2023 |
| FY2021 | Jan 1, 2021 | 250.80M | Feb 23, 2022 |
| FY2020 | Jan 3, 2020 | 249.90M | Feb 26, 2021 |
| FY2019 | Dec 28, 2018 | 250.90M | Feb 28, 2020 |
| FY2018 | Dec 29, 2017 | 248.90M | Feb 22, 2019 |
| FY2017 | Dec 30, 2016 | 251.30M | Feb 27, 2018 |